Holding(s) in Company

Allergy Therapeutics PLC
14 April 2005


                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company

Allergy Therapeutics plc

2. Name of shareholder having a major interest

BriTel Fund Nominees Ltd

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18

BriTel Fund Trustees Limited
The Trustees of the BT Pension Scheme

4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them

BriTel Fund Nominees Ltd

5. Number of shares / amount of stock acquired

Not known

6. Percentage of issued class

Not known

7. Number of shares / amount of stock disposed

Not known

8. Percentage of issued class

Not known

9. Class of security

Ordinary shares

10. Date of transaction

Not known

11. Date company informed

13 April 2005

12. Total holding following this notification

2,583,773

13. Total percentage holding of issued class following this notification

4.104%

14. Any additional information

-

15. Name of contact and telephone number for queries

Ian Postlethwaite - 01903 844720

16. Name and signature of authorised company official responsible for making
this notification

Ian Postlethwaite

Date of notification

14 April 2005

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.




                      This information is provided by RNS
            The company news service from the London Stock Exchange